Early detection of recurrence after curative resection for colorectal cancer – obstacles when using soluble biomarkers?

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
   PubMed Web of Science ®Google Scholar
• Jamal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Ytting H, Christensen IJ, Thiel S, Jensenius JC, Nielsen HJ. Serum MASP–2 in colorectal cancer: relation to recurrence and mortality. Clin Cancer Res 2005;11:1441–6.
   PubMed Web of Science ®Google Scholar
• Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five–year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010;97:1638–45.
   PubMed Web of Science ®Google Scholar
• Jeffrey M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2007;1:CD002200.
   Google Scholar
• Søreide K, Traeland JH, Stokkeland PJ, Glomsaker T, Søreide JA, Kørner H. Adherence to national guidelines for surveillance after curative resection of non-metastatic colon and rectum cancer: a survey among Norwegian gastrointestinal surgeons. Colorectal Dis 2012;12:320–4.
   Google Scholar
• Kanzaki R, Higashiyama M, Oda K, Fujiwara A, Tokunaga T, Maeda J, Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma. Am J Surg 2011;202:419–26.
   PubMed Web of Science ®Google Scholar
• Chua T, Morris DL. Therapeutic potential of surgery for metastatic colorectal cancer. Scand J Gastroenterol 2012;47:258–68.
   PubMed Web of Science ®Google Scholar
• Chua TC, Pelz JO, Morris DL. Surgery for colorectal peritoneal carcinomatosis. Scand J Gastroenterol 2012;47:277–85.
   PubMed Web of Science ®Google Scholar
• McFall MR, Woods WG, Miles WF. Colonoscopic surveillance after curative colorectal resection: results of an empirical surveillance program. Colorectal Dis 2003;5:233–40.
   PubMedGoogle Scholar
• Salz T, Weinberger M, Ayanian JZ, Brewer NT, Earle CC, Elston Lafata J, Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res 2010;10:256–61.
   PubMed Web of Science ®Google Scholar
• Hollington P, Tiong L, Young G. Timing and detection of metachronous colorectal cancer. ANZ J Surg 2011;81:272–4.
   PubMed Web of Science ®Google Scholar
• Wille-Jorgensen P, Laurberg S, Syk I, Dziki A, Renehan A. A pragmatic study to assess the frequency of surveillance tests after curative resection in patients with stage II and II colorectal cancer - a randomized study. www.colofol.com.
   Google Scholar
• Maas M, Rutten IJ, Nelemans PJ, Lambregts DM, Cappendijk VC, Beets GL, What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancer. Eur J Nucl Med Imaging 2011;38:1560–71.
   PubMed Web of Science ®Google Scholar
• Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny M, MacDonald JS, ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313–27.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007;43:1348–60.
   PubMed Web of Science ®Google Scholar
• Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brünner N, Chan DW, National Academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast and ovarian cancers. Clin Chem 2008;54:11–79.
   PubMed Web of Science ®Google Scholar
• Scheer A, Auer RA. Surveillance after curative resection of colorectal cancer. Clin Colon Rectal Surg 2009;22:242–50.
   PubMedGoogle Scholar
• Nielsen HJ, Brünner N, Jørgensen LN, Olsen J, Rahr HB, Thygesen K, Plasma TIMP–1 and CEA in detection of primary colorectal cancer: a prospective, population-based study of 4509 high-risk individuals. Scand J Gastroenterol 2011;46:60–9.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Christensen IJ, Sørensen S, Moesgaard F, Brünner N. Preoperative plasma plasminogen activator inhibitor type–1 and serum C-reactive protein levels in patients with colorectal cancer. Ann Surg Oncol 2000;7:617–23.
   PubMed Web of Science ®Google Scholar
• Holten-Andersen MN, Nielsen HJ, Sørensen S, Jensen V, Brünner N, Christensen IJ. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. Eur J Cancer 2006;42:1889–96.
   PubMed Web of Science ®Google Scholar
• Habermann JK, Roblick UJ, Luke BT, Prieto DA, Finlay WJ, Podust VN, Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors. Gastroenterology 2006;131:1020–9.
   PubMed Web of Science ®Google Scholar
• Thurison T, Lomholt AF, Rasch MG, Lund IK, Nielsen HJ, Christensen IJ, A new assay for measurement of the liberated domain I of the urokinase receptor in plasma improves the prediction of survival in colorectal cancer. Clin Chem 2010;56:1636–40.
   PubMed Web of Science ®Google Scholar
• Ytting H, Christensen IJ, Thiel S, Jensenius JC, Nielsen HJ. Pre- and postoperative levels in serum mannan–binding lectin associated protease–2: a prognostic marker in colorectal cancer. Hum Immunol 2008;69:414–20.
   PubMed Web of Science ®Google Scholar
• Werther K, Sørensen S, Christensen IJ, Nielsen HJ. Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer. Acta Oncol 2003;42:837–45.
   PubMed Web of Science ®Google Scholar
• Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. High serum YKL–40 level after surgery for colorectal carcinoma is related to short survival. Cancer 2002;95:267–74.
   PubMed Web of Science ®Google Scholar
• Ytting H, Christensen IJ, Basse L, Lykke J, Thiel S, Jensenius JC, Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol 2006;144:239–46.
   PubMed Web of Science ®Google Scholar
• Hammer JH, Basse L, Svendsen MN, Werther K, Brünner N, Christensen IJ, Impact of elective resection on plasma TIMP–1 levels in patients with colon cancer. Colorectal Dis 2006;8:168–72.
   PubMed Web of Science ®Google Scholar
• Frederiksen C, Lomholt AF, Davis GJ, Dowell BL, Blankenstein MA, Christensen IJ, Changes in plasma TIMP–1 levels after resection for primary colorectal cancer. Anticancer Res 2009;29:75–81.
   PubMed Web of Science ®Google Scholar
• Aldulaymi BH, Christensen IJ, Söletormos G, Jess P, Nielsen SE, Brünner N, Changes in soluble CEA and TIMP–1 levels during adjuvant chemotherapy for stage III colon cancer. Anticancer Res 2010;30:233–7.
   PubMed Web of Science ®Google Scholar
• Aldulaymi BH, Christensen IJ, Söletormos G, Jess P, Nielsen SE, Laurberg S, Chemoradiation-induced changes in serum CEA and plasma TIMP–1 in patients with locally advanced rectal cancer. Anticancer Res 2010;30:4755–9.
   PubMed Web of Science ®Google Scholar
• Eggermont AM, Steller EP, Sugarbaker PH. Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin–2 and lymphokine-activated killer cells. Surgery 1987;102:71–8.
   PubMed Web of Science ®Google Scholar
• Bouvy ND, Marquet RL, Jeekel J, Bonjer HJ. Laparoscopic surgery is associated with less tumour growth stimulation than conventional surgery: an experimental study. Br J Surg 1997;84:358–61.
   PubMed Web of Science ®Google Scholar
• Oosterling SJ, van der Bij GJ, van Egmond M, van der Sijp JRM. Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol 2005;31:29–37.
   PubMed Web of Science ®Google Scholar
• Clinical Outcomes of Surgical Therapy Study Group. A Comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004;350:2050–9.
   PubMed Web of Science ®Google Scholar
• Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2012;97:1638–45.
   Web of Science ®Google Scholar